Cipla on Thursday slashed the prices of its three generic cancer drugs — Erlocip, Docetax and Capegard — by up to 64 per cent. The drugs are used for treatment of lung and pancreatic cancer, breast cancer, head and neck cancer, gastric cancer, bladder and colorectal and colon cancers.

More In: Today's Paper